These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30593829)

  • 1. Functional interdependence of hematopoietic stem cells and their niche in oncogene promotion of myeloproliferative neoplasms: the 159th biomedical version of "it takes two to tango".
    Zhan H; Kaushansky K
    Exp Hematol; 2019 Feb; 70():24-30. PubMed ID: 30593829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell approaches identify the molecular network driving malignant hematopoietic stem cell self-renewal.
    Shepherd MS; Li J; Wilson NK; Oedekoven CA; Li J; Belmonte M; Fink J; Prick JCM; Pask DC; Hamilton TL; Loeffler D; Rao A; Schröder T; Göttgens B; Green AR; Kent DG
    Blood; 2018 Aug; 132(8):791-803. PubMed ID: 29991556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of normal and neoplastic hematopoiesis is dependent on microenvironmental cells.
    Kaushansky K; Zhan H
    Adv Biol Regul; 2018 Aug; 69():11-15. PubMed ID: 29970351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JAK2V617F mutant endothelial cells promote neoplastic hematopoiesis in a mixed vascular microenvironment.
    Mazzeo C; Quan M; Wong H; Castiglione M; Kaushansky K; Zhan H
    Blood Cells Mol Dis; 2021 Sep; 90():102585. PubMed ID: 34139651
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Lin CHS; Zhang Y; Kaushansky K; Zhan H
    Haematologica; 2018 Jul; 103(7):1160-1168. PubMed ID: 29567773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hematopoietic Microenvironment in Myeloproliferative Neoplasms: The Interplay Between Nature (Stem Cells) and Nurture (the Niche).
    Zhan H; Kaushansky K
    Adv Exp Med Biol; 2020; 1273():135-145. PubMed ID: 33119879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK2V617F Mutant Megakaryocytes Contribute to Hematopoietic Aging in a Murine Model of Myeloproliferative Neoplasm.
    Lee S; Wong H; Castiglione M; Murphy M; Kaushansky K; Zhan H
    Stem Cells; 2022 Apr; 40(4):359-370. PubMed ID: 35260895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of pleckstrin-2 reverts lethality and vascular occlusions in JAK2V617F-positive myeloproliferative neoplasms.
    Zhao B; Mei Y; Cao L; Zhang J; Sumagin R; Yang J; Gao J; Schipma MJ; Wang Y; Thorsheim C; Zhao L; Stalker T; Stein B; Wen QJ; Crispino JD; Abrams CS; Ji P
    J Clin Invest; 2018 Jan; 128(1):125-140. PubMed ID: 29202466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The marrow stem cell niche in normal and malignant hematopoiesis.
    Kaushansky K; Zhan H
    Ann N Y Acad Sci; 2020 Apr; 1466(1):17-23. PubMed ID: 30767234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK2V617F Megakaryocytes Promote Hematopoietic Stem/Progenitor Cell Expansion in Mice Through Thrombopoietin/MPL Signaling.
    Zhang Y; Lin CHS; Kaushansky K; Zhan H
    Stem Cells; 2018 Nov; 36(11):1676-1684. PubMed ID: 30005133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Marrow Micro-Environment in Normal and Deranged Hematopoiesis: Opportunities for Regenerative Medicine and Therapies.
    Sarkaria SM; Decker M; Ding L
    Bioessays; 2018 Mar; 40(3):. PubMed ID: 29384206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia inhibits JAK2V617F activation via suppression of SHP-2 function in myeloproliferative neoplasm cells.
    Mitsumori T; Nozaki Y; Kawashima I; Yamamoto T; Shobu Y; Nakajima K; Morishita S; Komatsu N; Kirito K
    Exp Hematol; 2014 Sep; 42(9):783-92.e1. PubMed ID: 24860972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK2
    Zhan H; Ma Y; Lin CH; Kaushansky K
    Leukemia; 2016 Dec; 30(12):2332-2341. PubMed ID: 27133820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germline mutations in the bone marrow microenvironment and dysregulated hematopoiesis.
    Miller LH; Qu CK; Pauly M
    Exp Hematol; 2018 Oct; 66():17-26. PubMed ID: 30076950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms.
    Zhan H; Lin CHS; Segal Y; Kaushansky K
    Leukemia; 2018 Feb; 32(2):462-469. PubMed ID: 28744010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. JAK2
    Lin CH; Kaushansky K; Zhan H
    Blood Cells Mol Dis; 2016 Nov; 62():42-48. PubMed ID: 27865175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms.
    Prick J; de Haan G; Green AR; Kent DG
    Exp Hematol; 2014 Oct; 42(10):841-51. PubMed ID: 25201757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloproliferative neoplasm stem cells.
    Mead AJ; Mullally A
    Blood; 2017 Mar; 129(12):1607-1616. PubMed ID: 28159736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ptch2 loss drives myeloproliferation and myeloproliferative neoplasm progression.
    Klein C; Zwick A; Kissel S; Forster CU; Pfeifer D; Follo M; Illert AL; Decker S; Benkler T; Pahl H; Oostendorp RA; Aumann K; Duyster J; Dierks C
    J Exp Med; 2016 Feb; 213(2):273-90. PubMed ID: 26834157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid, CYP26, and drug resistance in the stem cell niche.
    Alonso S; Jones RJ; Ghiaur G
    Exp Hematol; 2017 Oct; 54():17-25. PubMed ID: 28754309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.